Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
31467 | 152 | 32.1 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
3238 | 2 | ARBIDOL//VOPROSY VIRUSOLOGII//COOPERAT MED | 2003 |
31467 | 1 | THYMOPENTIN ANALOGS//EXOGENOUS UBIQUITIN//EXTRACELLULAR UBIQUITIN | 152 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THYMOPENTIN ANALOGS | authKW | 642851 | 3% | 80% | 4 |
2 | EXOGENOUS UBIQUITIN | authKW | 602675 | 2% | 100% | 3 |
3 | EXTRACELLULAR UBIQUITIN | authKW | 602675 | 2% | 100% | 3 |
4 | HISTOCOMPATIBILITY ANTIGEN | authKW | 482133 | 4% | 40% | 6 |
5 | UBIQUITIN FRAGMENTS | authKW | 452005 | 2% | 75% | 3 |
6 | 1 2 DIDEHYDROPROLINES | authKW | 401783 | 1% | 100% | 2 |
7 | DIMERIC ANALOGS | authKW | 401783 | 1% | 100% | 2 |
8 | MHC FRAGMENTS | authKW | 401783 | 1% | 100% | 2 |
9 | SERUM UBIQUITIN | authKW | 401783 | 1% | 100% | 2 |
10 | THYMOPENTIN ANALOGUES | authKW | 401783 | 1% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 282 | 38% | 0% | 57 |
2 | Critical Care Medicine | 157 | 7% | 0% | 10 |
3 | Chemistry, Organic | 116 | 14% | 0% | 21 |
4 | Immunology | 44 | 10% | 0% | 15 |
5 | Chemistry, Multidisciplinary | 39 | 13% | 0% | 20 |
6 | Biophysics | 27 | 6% | 0% | 9 |
7 | Surgery | 26 | 9% | 0% | 14 |
8 | Hematology | 24 | 5% | 0% | 7 |
9 | Medical Laboratory Technology | 16 | 2% | 0% | 3 |
10 | Cell Biology | 12 | 7% | 0% | 10 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOCHEM BIOTECHNOL TECH BIOCHEM | 200892 | 1% | 100% | 1 |
2 | DAUGHTRY SURG SURG CRIT CARE | 200892 | 1% | 100% | 1 |
3 | DAUGHTRY SURG TRAUMA | 200892 | 1% | 100% | 1 |
4 | DEWITT DAUGHTY FAMILY SURG | 200892 | 1% | 100% | 1 |
5 | FAHAJAMES H QUILLEN VET AFFAIRS MED | 200892 | 1% | 100% | 1 |
6 | ONCOIMMUNEDERMATOL | 200892 | 1% | 100% | 1 |
7 | MOL PHARMACOL THER EUT | 125278 | 7% | 6% | 11 |
8 | RYDER TRAUMA TRAUMA SURG CRIT CARE | 100445 | 1% | 50% | 1 |
9 | IMMUNOL EXPTL THER Y | 66963 | 1% | 33% | 1 |
10 | IMMUNOL EXPT THER Y | 61301 | 10% | 2% | 15 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH | 2881 | 4% | 0% | 6 |
2 | JOURNAL OF PEPTIDE SCIENCE | 2785 | 3% | 0% | 5 |
3 | LIEBIGS ANNALEN DER CHEMIE | 996 | 3% | 0% | 4 |
4 | ACTA BIOCHIMICA POLONICA | 657 | 2% | 0% | 3 |
5 | POLISH JOURNAL OF CHEMISTRY | 597 | 3% | 0% | 4 |
6 | PEPTIDES | 567 | 3% | 0% | 5 |
7 | JOURNAL OF BURN CARE & RESEARCH | 516 | 1% | 0% | 2 |
8 | COMPREHENSIVE PHYSIOLOGY | 500 | 1% | 0% | 1 |
9 | MOLECULAR IMMUNOLOGY | 451 | 3% | 0% | 4 |
10 | FEBS OPEN BIO | 425 | 1% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THYMOPENTIN ANALOGS | 642851 | 3% | 80% | 4 | Search THYMOPENTIN+ANALOGS | Search THYMOPENTIN+ANALOGS |
2 | EXOGENOUS UBIQUITIN | 602675 | 2% | 100% | 3 | Search EXOGENOUS+UBIQUITIN | Search EXOGENOUS+UBIQUITIN |
3 | EXTRACELLULAR UBIQUITIN | 602675 | 2% | 100% | 3 | Search EXTRACELLULAR+UBIQUITIN | Search EXTRACELLULAR+UBIQUITIN |
4 | HISTOCOMPATIBILITY ANTIGEN | 482133 | 4% | 40% | 6 | Search HISTOCOMPATIBILITY+ANTIGEN | Search HISTOCOMPATIBILITY+ANTIGEN |
5 | UBIQUITIN FRAGMENTS | 452005 | 2% | 75% | 3 | Search UBIQUITIN+FRAGMENTS | Search UBIQUITIN+FRAGMENTS |
6 | 1 2 DIDEHYDROPROLINES | 401783 | 1% | 100% | 2 | Search 1+2+DIDEHYDROPROLINES | Search 1+2+DIDEHYDROPROLINES |
7 | DIMERIC ANALOGS | 401783 | 1% | 100% | 2 | Search DIMERIC+ANALOGS | Search DIMERIC+ANALOGS |
8 | MHC FRAGMENTS | 401783 | 1% | 100% | 2 | Search MHC+FRAGMENTS | Search MHC+FRAGMENTS |
9 | SERUM UBIQUITIN | 401783 | 1% | 100% | 2 | Search SERUM+UBIQUITIN | Search SERUM+UBIQUITIN |
10 | THYMOPENTIN ANALOGUES | 401783 | 1% | 100% | 2 | Search THYMOPENTIN+ANALOGUES | Search THYMOPENTIN+ANALOGUES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BACH, HH , WONG, YM , LAPORTE, HM , GAMELLI, RL , MAJETSCHAK, M , (2016) PHARMACOLOGICAL TARGETING OF CHEMOKINE (C-X-C MOTIF) RECEPTOR 4 IN PORCINE POLYTRAUMA AND HEMORRHAGE MODELS.JOURNAL OF TRAUMA AND ACUTE CARE SURGERY. VOL. 80. ISSUE 1. P. 102 -110 | 23 | 66% | 0 |
2 | WONG, YM , LAPORTE, HM , ALBEE, LJ , BAKER, TA , BACH, HH , VANA, PG , EVANS, AE , GAMELLI, RL , MAJETSCHAK, M , (2017) UBIQUITIN URINE LEVELS IN BURN PATIENTS.JOURNAL OF BURN CARE & RESEARCH. VOL. 38. ISSUE 1. P. E133 -E143 | 20 | 37% | 0 |
3 | GARCIA-COVARRUBIAS, L , MANNING, EW , SORELL, LT , PHAM, SM , MAJETSCHAK, M , (2008) UBIQUITIN ENHANCES THE TH2 CYTOKINE RESPONSE AND ATTENUATES ISCHEMIA-REPERFUSION INJURY IN THE LUNG.CRITICAL CARE MEDICINE. VOL. 36. ISSUE 3. P. 979-982 | 11 | 79% | 13 |
4 | SAINI, V , MARCHESE, A , MAJETSCHAK, M , (2010) CXC CHEMOKINE RECEPTOR 4 IS A CELL SURFACE RECEPTOR FOR EXTRACELLULAR UBIQUITIN.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 285. ISSUE 20. P. 15566 -15576 | 18 | 41% | 48 |
5 | EARLE, SA , EL-HADDAD, A , PATEL, MB , RUIZ, P , PHAM, SM , MAJETSCHAK, M , (2006) PROLONGATION OF SKIN GRAFT SURVIVAL BY EXOGENOUS UBIQUITIN.TRANSPLANTATION. VOL. 82. ISSUE 11. P. 1544 -1546 | 12 | 71% | 10 |
6 | JOB, F , SETTELE, F , LOREY, S , RUNDFELDT, C , BAUMANN, L , BECK-SICKINGER, AG , HAUPTS, U , LILIE, H , BOSSE-DOENECKE, E , (2015) UBIQUITIN IS A VERSATILE SCAFFOLD PROTEIN FOR THE GENERATION OF MOLECULES WITH DE NOVO BINDING AND ADVANTAGEOUS DRUG-LIKE PROPERTIES.FEBS OPEN BIO. VOL. 5. ISSUE . P. 579 -593 | 25 | 25% | 0 |
7 | MAJETSCHAK, M , ZEDLER, S , HOSTMANN, A , SORELL, LT , PATEL, MB , NOVAR, LT , KRAFT, R , HABIB, F , DE MOYA, MA , ERTEL, W , ET AL (2008) SYSTEMIC UBIQUITIN RELEASE AFTER BLUNT TRAUMA AND BURNS: ASSOCIATION WITH INJURY SEVERITY, POSTTRAUMATIC COMPLICATIONS, AND SURVIVAL.JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. VOL. 64. ISSUE 3. P. 586 -596 | 14 | 50% | 5 |
8 | BAKER, TA , ROMERO, J , BACH, HH , STROM, JA , GAMELLI, RL , MAJETSCHAK, M , (2012) EFFECTS OF EXOGENOUS UBIQUITIN IN A POLYTRAUMA MODEL WITH BLUNT CHEST TRAUMA.CRITICAL CARE MEDICINE. VOL. 40. ISSUE 8. P. 2376-2384 | 16 | 38% | 3 |
9 | JAREMKO, L , JAREMKO, M , PASIKOWSKI, P , CEBRAT, M , STEFANOWICZ, P , LISOWSKI, M , ARTYM, J , ZIMECKI, M , ZHUKOV, I , SZEWCZUK, Z , (2009) THE IMMUNOSUPPRESSIVE ACTIVITY AND SOLUTION STRUCTURES OF UBIQUITIN FRAGMENTS.BIOPOLYMERS. VOL. 91. ISSUE 6. P. 423 -431 | 15 | 42% | 13 |
10 | MAJETSCHAK, M , (2011) EXTRACELLULAR UBIQUITIN: IMMUNE MODULATOR AND ENDOGENOUS OPPONENT OF DAMAGE-ASSOCIATED MOLECULAR PATTERN MOLECULES.JOURNAL OF LEUKOCYTE BIOLOGY. VOL. 89. ISSUE 2. P. 205-219 | 29 | 18% | 34 |
Classes with closest relation at Level 1 |